[1]
K., S., Sonia, S.S., Reddy, C.P., Rao, R.K. and R Naidu, M.U. 2016. Comparative evaluation of H1 receptor blocking activity and safety of newer H1antagonist mizolastine with loratadine and placebo: a randomized double blind three way crossover study. International Journal of Basic & Clinical Pharmacology. 5, 3 (Dec. 2016), 661–675. DOI:https://doi.org/10.18203/2319-2003.ijbcp20161499.